Latest Breaking News On - Wales cancer network - Page 1 : vimarsana.com

FDA grants Priority Review to Roche's inavolisib for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation

Priority Review recognises the best-in-class potential of the inavolisib-based regimen for patients in urgent need of new treatment options1,2Additional analyses of INAVO120 will be presented in an...

FDA grants Priority Review to Roche's inavolisib for

Priority Review recognises the best-in-class potential of the inavolisib-based regimen for patients in urgent need of new treatment options1,2Additional...

FDA grants Breakthrough Therapy Designation to Roche's inavolisib for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation

The designation is based on Phase III INAVO120 results, showing the inavolisib-based regimen more than doubled progression-free survival compared with palbociclib and fulvestrant alone in the...

Wales among worst countries for people surviving cancers, data suggests

Data suggests Wales ranks 32nd out of 33 similarly wealthy nations for surviving stomach cancer.

Lung cancer screening in Wales lags behind England - charity

A grandmother recalls how as a teenager she was rewarded with cigarettes for doing the ironing.

Cancer Research UK funds Hywel Dda prostate cancer scheme

PEOPLE in west Wales who are suspected of having prostate cancer can now get quick diagnoses with a new scheme.

Research Advances Access To Prehabilitation For Cancer Patients

MS calls for Rapid Diagnosis Centre at Bronglais

CEREDIGION MS Elin Jones is calling on Hywel Dda Health Board to open a centre in Bronglais, in order to improve accessibility for urgent diagnosis for residents of Ceredigion and mid Wales.

New three year cancer action plan introduced in Wales

The action plan aims to improve cancer patient outcomes and enhance patient experience.

"Vital" new three year cancer action plan introduced in Wales

The action plan aims to improve cancer patient outcomes and enhance patient experience.